Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Integrative-omics Study to Identify New Biomarkers of Cardiomyopathy Patients in China

NCT03076580 is registered in ClinicalTrials.gov with Beijing Institute of Heart, Lung and Blood Vessel Diseases as lead sponsor.

NCT NCT03076580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03076580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Integrative-omics Study to Identify New Biomarkers of Cardiomyopathy Patients in China
Lead sponsor
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2015
Completion date
December 31, 2021
Enrollment
2,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy, hypertrophic cardiomyopathy, left ventricular non-compaction, restrictive cardiomyopathy